Moreover, interventions of prophylactic oxytocin to prevent PPH using Uniject in community settings in Ghana and Angola have been proven feasible and effective to reduce PPH.[61,62] However, the potential advantage of using Uniject instead of standard oxytocin to facilitate administration and increase coverage has not been evaluated in any clinical trial yet. Here, OXT is linked to pulmonary arterial hypertension.